Qiagen N.V.

  • WKN: A2DKCH
  • ISIN: NL0012169213
  • Land: The Netherlands

Nachricht vom 10.01.2020 | 22:03

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

QIAGEN N.V.
10.01.2020 / 22:03
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The AFM (the Netherlands Authority For the Financial Markets has informed us on January 8, 2020 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 02 jan 2020
Person obliged to notify: Goldman Sachs Group Inc., The
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Ordinary share 1.041.560,00 1.041.549,58 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
Swap 238.156,00 238.156,00 Potential Potential Indirectly - Goldman, Sachs & Co. Wertpapier GmbH In cash
Swap 115.291,00 115.291,00 Potential Potential Indirectly - Goldman Sachs International In cash
Ordinary share 452.142,00 452.137,48 Real Real Indirectly - Goldman Sachs Asset Management, L.P. Physical Delivery
Swap 2.044,00 2.044,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC In cash
Contract for difference 196.706,00 196.706,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC In cash
Option 3.863.782,00 3.863.782,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Ordinary share 1.215,00 1.215,00 Real Real Indirectly - United Capital Financial Advisers, LLC Physical Delivery
Ordinary share 2.389,00 2.389,00 Real Real Indirectly - Goldman Sachs Asset Management International Physical Delivery
Warrant 115.291,00 115.291,00 Potential Potential Indirectly - Goldman, Sachs & Co. Wertpapier GmbH In cash
Warrant 219.192,00 219.192,00 Potential Potential Indirectly - Goldman Sachs International In cash
Call-option 280.200,00 280.200,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Ordinary share 93.106,00 93.105,07 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Convertible bond 282.527,00 282.527,00 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
 

 

Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 2,99 % 0,00 % 0,00 % 0,20 % 2,79 %
Voting rights 2,99 % 0,00 % 0,00 % 0,20 % 2,79 %
 

Distribution in numbers (short)

Number of shares Manner of disposal
0,00 Indirectly - Goldman Sachs International
0,00 Indirectly - Goldman Sachs & Co. LLC
 

Distribution in percentages (short)

Type Directly potential Indirectly potential
Capital interest 0,00 % 0,00 %
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=83424&KeyWords=qiagen



10.01.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

MBH Corporation. Hohes Kurspotenzial

Die MBH Corporation plc hat in den vergangenen Berichtsperioden eine sehr hohe M&A-Aktivität aufgezeigt. Unter Anwendung der so genannten Agglomeration Methodology hat die Beteiligungsgesellschaft branchenübergreifend seit 2018 11 Beteiligungen erworben. Bei einem Pro-Forma-Umsatz der Beteiligungsgesellschaften von über 120 Mio. GBP und einem Pro-Forma-EBITDA in Höhe von über 11 Mio. GBP weist die MBH derzeit eine Marktkapitalisierung von umgerechnet gerade einmal 19,8 Mio. GBP auf. Ausgehend vom aktuellen Aktienkurs liegt zu unserem Kursziel in Höhe von 1,95 € ein hohes Kurspotenzial vor

News im Fokus

Fresenius Medical Care AG & Co. KGaA verschiebt Hauptversammlung 2020

30. März 2020, 09:01

Aktueller Webcast

SeaChange Corporation

Fourth Quarter Fiscal Year 2020 Results

06. April 2020

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Kaufen

27. März 2020